85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

14 trials found

diseases per page:

Showing 1 to 10 of 14 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03720483 (ClinicalTrials.gov)	January 2022	18/7/2018	Inhaled NAC in Treatment of IPF	Pilot Study to Evaluate Inhaled N-Acetylcysteine in Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis (IPF)	Drug: N-acetyl cysteine then Placebo;Drug: Placebo then N-acetyl cysteine	University of Colorado, Denver	NULL	Withdrawn	40 Years	75 Years	All	0	Phase 1/Phase 2	United States
2	JPRN-UMIN000015508	2015/01/01	24/10/2014	A prospective randomized, multicenter trial evaluating the efficacy and safety of combined therapy w ...	A prospective randomized, multicenter trial evaluating the efficacy and safety of combined therapy w ...	Idiopathic pulmonary fibrosis	Using Micro Airnebulizers and vibration mesh technology (NE-U07, Omron, Tokyo, Japan), patients rece ...	Grant for Research on Diffuse Lung Disease from the Ministry of Health, Labour and Welfare of Japan. ...	NULL	Complete: follow-up complete	40years-old	Not applicable	Male and Female	150	Not selected	Japan
3	EUCTR2012-000564-14-GB (EUCTR)	11/09/2013	04/07/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil ® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Belgium;Denmark;Austria;Germany;Italy;United Kingdom;Sweden
4	EUCTR2012-000564-14-DK (EUCTR)	28/08/2013	12/07/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil ® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Austria;Denmark;Germany;United Kingdom;Italy;Sweden
5	NCT02707640 (ClinicalTrials.gov)	August 2013	9/3/2016	A Study to Assess the Safety and Tolerability of N-AcetylcysteineWhen Administered With Pirfenidone ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N-Ac ...	Idiopathic Pulmonary Fibrosis	Drug: Matching Placebo;Drug: N-acetylcysteine;Drug: Pirfenidone	Hoffmann-La Roche	NULL	Completed	40 Years	80 Years	All	123	Phase 2	Austria;Belgium;Denmark;France;Germany;Italy;Sweden;United Kingdom
6	EUCTR2012-000564-14-AT (EUCTR)	19/07/2013	11/06/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil ® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Denmark;Austria;Germany;United Kingdom;Italy;Sweden
7	EUCTR2012-000564-14-IT (EUCTR)	17/07/2013	07/06/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 16.0;Level: PT;Classification code ...	Trade Name: Fluimucil ® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	250	Phase 2	Belgium;Denmark;Austria;Germany;United Kingdom;Italy;Sweden
8	EUCTR2012-000564-14-DE (EUCTR)	17/07/2013	29/05/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil ® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Denmark;Austria;Germany;United Kingdom;Italy;Sweden
9	EUCTR2012-000564-14-SE (EUCTR)	25/06/2013	24/05/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil ® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Denmark;Austria;Germany;United Kingdom;Italy;Sweden
10	EUCTR2012-000564-14-BE (EUCTR)	18/06/2013	30/04/2013	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N–Ac ...	Patients with Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 17.0;Level: PT;Classification code ...	Trade Name: Fluimucil ® 600 mg effervescent tablets INN or Proposed INN: ACETYLCYSTEINE Other descripti ...	InterMune International AG.	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Belgium;Denmark;Austria;Germany;United Kingdom;Italy;Sweden

First Previous1 2Next Last